Medical Hope, Legal Pitfalls: Potential Legal Issues in the Emerging Field of Oncofertility

Dolin, Gregory; Roberts, Dorothy E.; Rodríguez, Lina; Woodruff, Teresa K.

doi:10.1007/978-1-4419-6518-9_9

Cited by 24 publications

(13 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is clear from our research that this is largely uncharted legal and policy territory. However, the recent coining of the term ''Oncofertility'' and the increased attention on the legal and medical implications associated with cancer related infertility are likely to highlight the need for examination of this situation on all fronts (18). We suggest there is a strong argument for policies that require coverage or offer of coverage for infertility of cancer survivors and fertility preservation options before treatment, much in the same way the health care costs of other side effects of cancer treatment are covered for those with a cancer diagnosis (e.g., lymphedema, alopecia).…”

Section: Discussionmentioning

confidence: 97%

State laws and regulations addressing third-party reimbursement for infertility treatment: implications for cancer survivors

Quinn

Vadaparampil

Lowrey

et al. 2011

Fertility and Sterility

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 97%

State laws and regulations addressing third-party reimbursement for infertility treatment: implications for cancer survivors

Quinn

Vadaparampil

Lowrey

et al. 2011

Fertility and Sterility

View full text Add to dashboard Cite

“…Without a strong disease affiliation, such as in cancer, cardiovascular, and Alzheimer's research, strong advocacy and support for our discipline is lacking. Finally, there are societal, cultural, legal, and religious apprehensions that surround our field due to the ethically charged and controversial nature of reproductive research [27][28][29][30][31]. Gametes and embryos, for example, have the potential to give rise to the next generation; embryonic stem cells under the right conditions can transmogrify into all cell lineages; contraception prevents fertilization and implantation, and Assisted Reproduction Technologies (ART) move biological events from the body to the bench [32,33].…”

Section: Discussionmentioning

confidence: 99%

A small field for fertile science: the low visibility of reproductive science in high impact journals

Duncan

Derman

Woodruff

2014

J Assist Reprod Genet

Self Cite

View full text Add to dashboard Cite

Purpose Our success as a field and as individuals in reproductive science and medicine relies on our ability to produce high quality work that has broad visibility and impact. A common metric for assessing such success is the quantity of publications that are published in journals with high impact factors. It is unclear, however, how frequently work related to reproductive science and medicine actually appears in what are considered the highest impact journals. Methods To address this gap in knowledge, we first determined how the field of reproductive biology in general compared to other research areas in terms of composite journal impact factor. Second, using a targeted search approach in the PubMed database, we examined the relationship between a journal's impact factor and the number of reproductive research articles published per journal issue. Results We found that compared to other major scientific disciplines, our field lacks journals with impact factors above 4. In addition, primary original research articles on reproductionirrespective of male or female search terms-do not appear often in high impact journals. Instead, there is an increased percentage of secondary reproductive literature in high impact journals compared to topic-specific journals of lower impact. Conclusions There are likely several explanations for why reproductive science and medicine has low visibility, including the field's small relative size, its lack of a specific disease and associated strong advocacy, and its surrounding social, ethical, and political unease. Nevertheless, there are concrete actions we can take to minimize the role of impact factor in our evaluation while simultaneously increasing influence through global awareness of the importance and need for reproductive research.

show abstract

“…In cases in which intervention was also required, we needed plans for Institutional Review Board (IRB)-approved experimental options and new lines of communication between oncology and reproductive endocrinology. We needed legal, ethical, and insurance and reimbursement issues to be addressed (Campo-Engelstein 2010 a ,b, 2011, Dolin et al . 2010).…”

Section: The Oncofertility Consortiummentioning

confidence: 99%

“…The conversation about reproductive health in young patients diagnosed with a fertility-threatening disease or treatment is particularly complex, covering topics from basic biology, medical practice planning, health access, and reproductive rights, to ethical, social, moral, cultural, religious, and personal perspectives. The conversation includes many stakeholders – practitioners, patients, parents, and partners, and even the public, policymakers, and advocates (Woodruff & Snyder 2007, Dolin et al . 2010, Woodruff et al .…”

Section: Introductionmentioning

confidence: 99%

Oncofertility: a grand collaboration between reproductive medicine and oncology

Woodruff¹

2015

Reproduction

View full text Add to dashboard Cite

In 2007, I was asked by the University of Calgary to participate in a symposium called ‘Pushing the Boundaries – Advances that Will Change the World in 20 Years’. My topic was oncofertility, a word I had just coined to describe the intersection of two disciplines – oncology and fertility – and I was thrilled to share my passion for this new field and help young women with cancer protect their future reproductive health. Fertility preservation in the cancer setting lacked a concerted effort to bridge the disciplines in an organized manner. In early 2015, I was delighted to deliver a presentation for the Society for Reproduction and Fertility titled ‘Sex in Three Cities’, where I gave an update on the oncofertility movement, a remarkable cross-disciplinary, global collaboration created to address the fertility preservation needs of young cancer patients. During my tour of the UK, I was impressed by the interest among the society and its members to engage colleagues outside the discipline as well as the public in a dialogue about cutting-edge reproductive science. In this invited review, I will describe the work of the Oncofertility Consortium to provide fertility preservation options in the cancer setting and accelerate the acceptance of this critical topic on a global scale. I hope that one day this word and field it created will change the world for women who had been left out of the equation for far too long.

show abstract

Medical Hope, Legal Pitfalls: Potential Legal Issues in the Emerging Field of Oncofertility

Cited by 24 publications

References 26 publications

State laws and regulations addressing third-party reimbursement for infertility treatment: implications for cancer survivors

State laws and regulations addressing third-party reimbursement for infertility treatment: implications for cancer survivors

A small field for fertile science: the low visibility of reproductive science in high impact journals

Oncofertility: a grand collaboration between reproductive medicine and oncology

Contact Info

Product

Resources

About